Статья

The urgent need for pan-antiviral agents: From multitarget discovery to multiscale design

V. Kleandrova, A. Speck-Planche,
2021

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • V. Kleandrova
    Laboratory of Fundamental and Applied Research of Quality and Technology of Food Production, Moscow State University of Food Production, Volokolamskoe shosse 11, Moscow, Russian Federation
  • A. Speck-Planche
    Programa Institucional de Fomento A la Investigación Desarrollo e Innovación, Universidad Tecnológica Metropolitana, Ignacio Valdivieso 2409, San Joaquín, Santiago, Chile
Название журнала
  • Future Medicinal Chemistry
Том
  • 13
Выпуск
  • 1
Страницы
  • 5-8
Ключевые слова
  • antivirus agent; bevacizumab; chloroquine; darunavir; favipiravir; galidesivir; hydroxychloroquine; leronlimab; lopinavir plus ritonavir; remdesivir; antivirus agent; computer model; drug approval; drug design; drug efficacy; drug repositioning; Food and Drug Administration; priority journal; Review; viral clearance; drug delivery system; drug development; drug therapy; health service; human; procedures; synthesis; Antiviral Agents; COVID-19; Drug Delivery Systems; Drug Design; Drug Discovery; Drug Repositioning; Health Services Needs and Demand; Humans
Издатель
  • Future Medicine Ltd.
Тип документа
  • Review
Источник
  • scopus